Skip to main content

People in the News: Dec 17, 2009

Premium

Mirna Therapeutics, a developer of microRNA therapeutics, said that it has added three outside directors to its board.

Joining the board are Chris Earl, an entrepreneur and investor; Corey Goodman, managing director of venture capital firm VenBio and co-founder of Exelixis; and Evan Melrose, founder and managing director of healthcare venture capital company PTV Sciences.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.